Vrba Jiri, Havlikova Marika, Gerhardova Denisa, Ulrichova Jitka
Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic.
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc 77515, Czech Republic.
Toxicol In Vitro. 2014 Jun;28(4):693-9. doi: 10.1016/j.tiv.2014.02.008. Epub 2014 Feb 27.
The protoberberine alkaloid palmatine is present in preparations from medicinal plants such as Coptis chinensis and Corydalis yanhusuo. This study examined whether palmatine affects the expression of cytochromes P450 (CYPs) 1A1 and 1A2 in primary cultures of human hepatocytes and human hepatoma HepG2 cells grown as monolayer or spheroids. Gene reporter assays showed that palmatine significantly activated the aryl hydrocarbon receptor (AhR) and increased the activity of CYP1A1 gene promoter in transiently transfected HepG2 cells. In HepG2 monolayer culture, palmatine also significantly increased mRNA and activity levels of CYP1A1, albeit with considerably less potency than 2,3,7,8-tetrachlorodibenzo-p-dioxin, a prototypical CYP1A inducer. On the other hand, CYP1A activity was not significantly elevated by palmatine in HepG2 spheroids. Moreover, palmatine induced mild or negligible changes in CYP1A1 and CYP1A2 mRNA expression without affecting CYP1A activity levels in primary human hepatocytes. It is concluded that palmatine activates the AhR-CYP1A pathway in HepG2 monolayer, while the potential for CYP1A induction is irrelevant in cell systems which are closer to the in vivo situation, i.e. in HepG2 spheroids and primary cultures of human hepatocytes. Possible induction of CYP1A enzymes by palmatine in vivo remains to be investigated.
原小檗碱生物碱巴马汀存在于黄连和延胡索等药用植物的制剂中。本研究考察了巴马汀对人肝细胞原代培养物以及单层或球体生长的人肝癌HepG2细胞中细胞色素P450(CYP)1A1和1A2表达的影响。基因报告分析表明,巴马汀可显著激活芳烃受体(AhR),并增加瞬时转染的HepG2细胞中CYP1A1基因启动子的活性。在HepG2单层培养中,巴马汀也显著增加了CYP1A1的mRNA和活性水平,尽管其效力远低于典型的CYP1A诱导剂2,3,7,8-四氯二苯并对二恶英。另一方面,巴马汀在HepG2球体中并未显著提高CYP1A活性。此外,巴马汀在原代人肝细胞中诱导CYP1A1和CYP1A2 mRNA表达的变化轻微或可忽略不计,且不影响CYP1A活性水平。研究得出结论,巴马汀在HepG2单层中激活AhR-CYP1A途径,而在更接近体内情况的细胞系统(即HepG2球体和原代人肝细胞培养)中,CYP1A诱导潜力无关紧要。巴马汀在体内是否可能诱导CYP1A酶仍有待研究。